Clinical Case Scenario : QA

A 70-year-old man with known decompensated alcoholic liver cirrhosis presents to the ICU.

History

  • One-day history of worsening confusion, reduced urine output, and refractory hypotension despite fluids.
  • Hypertension, type 2 diabetes mellitus.
  • No history of chronic kidney disease before this admission.

 

Vital Signs

  • HR: 104/min, BP: 84/60 mmHg (MAP 64 on norepinephrine infusion).
  • Temp: 38.7°C.
  • SpO₂: 94% on 4L O₂ via nasal cannula.
  • RR: 22/min.

 

Laboratory Findings

  • Serum Na⁺: 172 mmol/L
  • Serum osmolarity: 350 mOsm/kg
  • pH: 7.32, HCO₃⁻: 18 mmol/L
  • MAP: 64 mmHg on norepinephrine infusion

 

Which of the following is the most appropriate way to use 3% NaCl during CRRT to safely manage this patient’s hypernatremia?

Clinical Case Scenario: QB

The same patient is started on continuous renal replacement therapy (CRRT). On day 1, his laboratory results are:

  • Serum sodium: 172 mmol/L
  • Weight: 70 kg
  • CRRT prescription: CVVHDF with dialysate sodium concentration of 140 mmol/L, total effluent rate 25 mL/kg/hr
  • No ongoing free water losses (insensible losses balanced by replacement)

To buffer sodium loss, you decide to infuse 3% NaCl via a central line during CRRT.
(Assume distribution volume of Na = 0.6 × body weight, and [Na] in 3% NaCl = 513 mmol/L).

What is the approximate rate (mL/hr) of 3% NaCl infusion required to limit the serum sodium drop to less than 10 mmol/L/day?